News Feature
Nature Biotechnology 25, 377 - 379 (2007)
Published online: 3 April 2007 | doi:10.1038/nbt0407-377
Making money and opening minds
Monya Baker1
- San Francisco
Abstract
Neurotechnology companies have promise, but lack funding and credibility. Monya Baker reports on this nascent area for startups.


